We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

No End In Sight In Plavix Battle

Law360 (August 21, 2006, 12:00 AM EDT) -- Attorneys spent a second day in court Monday arguing over whether Apotex’ generic version of the blockbuster blood thinner Plavix should be allowed on the market.

Sanofi-Aventis, the distributor of Plavix in Europe, and Bristol-Myers Squibb Co., which sells the drug in the United States, are seeking a preliminary injunction against the manufacturing and sale of the generic version of the drug.

Friday, attorneys for Bristol-Myers focused on whether the Apotex generic infringes a basic patent on Plavix that does not expire for at least another...
To view the full article, register now.